SCHEMBL2974124

SCHEMBL2974124

CCCCc1ccc(C2=Cc3cc(Br)ccc3C2C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
NFKB1 P19838 3/20 0.41
NFKB2 Q00653 3/20 0.41
RELA Q04206 3/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GAA P10253 1/20 0.37
EIF4A1 P60842 2/20 0.35
RARB P10826 2/20 0.35
S1PR1 P21453 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
FDFT1 P37268 1/20 0.34
SKP2 Q13309 1/20 0.34
HSD11B1 P28845 1/20 0.33
GPR84 Q9NQS5 1/20 0.33
NISCH Q9Y2I1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2969380 0.90 NPC1 (0.41) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL2966102 0.79 ALDH1A1 (0.38) NPC1RAB9ASMN1; SMN2MAPK1GAA
SCHEMBL2963789 0.77 MAPK1 (0.36) NPC1RAB9ASMN1; SMN2MAPK1ALDH1A1
SCHEMBL2962627 0.76 HSD11B1 (0.36) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL2969961 0.76 HSD11B1 (0.36) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL2970949 0.74 SKP2 (0.40) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL2968029 0.72 NPC1 (0.42) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL2050263 0.71 NPC1 (0.64) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL2970027 0.69 NPC1 (0.43) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL27881438 0.69 SMN1; SMN2 (0.59) NPC1RAB9ASMN1; SMN2NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 NPC1 4083/4885RAB9A 1848/4885SMN1; SMN2 4156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.